Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to "Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae"; Focus on griseofulvin.
Caplan AS, Chaturvedi S, Todd G, Sikora M, Ugwu-Dike PO, Pahalyants V, Taiwo D, Gold JAW. Caplan AS, et al. Among authors: ugwu dike po. J Am Acad Dermatol. 2025 Jan;92(1):e11-e12. doi: 10.1016/j.jaad.2024.06.109. Epub 2024 Sep 7. J Am Acad Dermatol. 2025. PMID: 39245365 Free PMC article. No abstract available.
Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study.
Wan G, Nguyen N, Leung BW, Rashdan H, Tang K, Roster K, Collier MR, Ugwu-Dike PO, Raval NS, Alexander NA, Jairath R, Phillipps J, Amadife M, Zhang S, Gusev A, Chen ST, Reynolds KL, LeBoeuf NR, Kwatra SG, Semenov YR. Wan G, et al. Among authors: ugwu dike po. J Am Acad Dermatol. 2024 Feb;90(2):418-420. doi: 10.1016/j.jaad.2023.09.082. Epub 2023 Oct 13. J Am Acad Dermatol. 2024. PMID: 37838257 No abstract available.
Geographic access to dermatologic care in urban underserved communities.
Roberson L, Ugwu-Dike P, Stevenson PA, Collier SM. Roberson L, et al. Among authors: ugwu dike p. J Am Acad Dermatol. 2024 Feb;90(2):410-412. doi: 10.1016/j.jaad.2023.09.079. Epub 2023 Oct 8. J Am Acad Dermatol. 2024. PMID: 37816411 Free PMC article. No abstract available.
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort Study.
Wan G, Nguyen N, Leung BW, Rashdan H, Tang K, Roster K, Collier MR, Ugwu-Dike PO, Raval NS, Alexander NA, Jairath R, Phillipps J, Amadife M, Zhang S, Gusev A, Chen ST, Reynolds KL, LeBoeuf NR, Kwatra SG, Semenov YR. Wan G, et al. Among authors: ugwu dike po. medRxiv [Preprint]. 2023 Aug 29:2023.08.28.23294695. doi: 10.1101/2023.08.28.23294695. medRxiv. 2023. Update in: J Am Acad Dermatol. 2024 Feb;90(2):418-420. doi: 10.1016/j.jaad.2023.09.082 PMID: 37693493 Free PMC article. Updated. Preprint.
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy.
Nguyen N, Wan G, Ugwu-Dike P, Alexander NA, Raval N, Zhang S, Jairath R, Phillipps J, Leung B, Roster K, Seo J, Lu C, Tang K, Choi MS, DeSimone MS, Theodosakis N, Amadife M, Cox N, Le TK, Liu F, Chen W, Bai X, Boland G, Liu D, Hurlbert MS, LeBoeuf N, Reynolds KL, Yu KH, Tsao H, Asgari M, Gusev A, Kwatra SG, Semenov YR. Nguyen N, et al. Among authors: ugwu dike p. J Am Acad Dermatol. 2023 Jun;88(6):1308-1316. doi: 10.1016/j.jaad.2023.02.014. Epub 2023 Feb 22. J Am Acad Dermatol. 2023. PMID: 36828138 Free PMC article.
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study.
Zhang S, Tang K, Wan G, Nguyen N, Lu C, Ugwu-Dike P, Raval N, Seo J, Alexander NA, Jairath R, Phillipps J, Leung BW, Roster K, Chen W, Zubiri L, Boland G, Chen ST, Tsao H, Demehri S, LeBoeuf NR, Reynolds KL, Yu KH, Gusev A, Kwatra SG, Semenov YR. Zhang S, et al. Among authors: ugwu dike p. J Am Acad Dermatol. 2023 May;88(5):1024-1032. doi: 10.1016/j.jaad.2022.12.048. Epub 2023 Feb 2. J Am Acad Dermatol. 2023. PMID: 36736626 Free PMC article.
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study.
Zhang S, Tang K, Wan G, Nguyen N, Lu C, Ugwu-Dike P, Raval N, Seo J, Alexander NA, Jairath R, Phillipps J, Leung BW, Roster K, Chen W, Zubiri L, Boland G, Chen ST, Tsao H, Demehri S, LeBoeuf NR, Reynolds KL, Yu KH, Gusev A, Kwatra SG, Semenov YR. Zhang S, et al. Among authors: ugwu dike p. medRxiv [Preprint]. 2023 Jan 18:2023.01.16.23284635. doi: 10.1101/2023.01.16.23284635. medRxiv. 2023. Update in: J Am Acad Dermatol. 2023 May;88(5):1024-1032. doi: 10.1016/j.jaad.2022.12.048 PMID: 36711758 Free PMC article. Updated. Preprint.
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study.
Tiu BC, Zubiri L, Iheke J, Pahalyants V, Theodosakis N, Ugwu-Dike P, Seo J, Tang K, Sise ME, Sullivan R, Naidoo J, Mooradian MJ, Semenov YR, Reynolds KL. Tiu BC, et al. Among authors: ugwu dike p. J Immunother Cancer. 2022 Jun;10(6):e004670. doi: 10.1136/jitc-2022-004670. J Immunother Cancer. 2022. PMID: 35705313 Free PMC article.
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.
Tang K, Seo J, Tiu BC, Le TK, Pahalyants V, Raval NS, Ugwu-Dike PO, Zubiri L, Naranbhai V, Carrington M, Gusev A, Reynolds KL, LeBoeuf NR, Asgari MM, Kwatra SG, Semenov YR. Tang K, et al. Among authors: ugwu dike po. JAMA Dermatol. 2022 Feb 1;158(2):189-193. doi: 10.1001/jamadermatol.2021.5476. JAMA Dermatol. 2022. PMID: 35019948 Free PMC article.
16 results